Skip to search formSkip to main contentSkip to account menu

iomeglamic acid

Known as: 5-((3-amino-2,4,6- triiodophenyl)methylamino)-5-oxopentanoic acid, N-methyl-N-(2,4,6-triiodo-3-aminophenyl)glutaramide acid 
National Institutes of Health

Related topics

Related topics

2 relations

Narrower (1)

Falignost

Broader (1)

Iodobenzenes

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1985
1985
[Improvement of the solubility of problem drugs. 1. Production of iomeglamic acid fused and solidified products].
The insoluble X-ray diagnostic iomeglamic acid could be converted to a more soluble modification by melting and solidifying it in… 
1975
1975
[Biotransformation of iomeglamic acid (Falignost)].
1974
1974
[Biotransformation of iomeglamic acid (Falignost)].
1972
1972
[Biotransformation of iomeglamic acid (Falignost)].
1972
1972
[Biotransformation of iomeglamic acid (Falignost)].
1972
1972
[Analysis of iomeglamic acid (Falignost)].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)